An interventional study of Isokinetic Training and Isokinetic Training Combined With Blood Flow Restriction in Patellofemoral Pain Syndrome, sponsored by Nanjing Mingzhou Rehabilitation Hospital. Completed at 1 site in China. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-08-25.
Sponsored by Nanjing Mingzhou Rehabilitation Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 11 studies in Patellofemoral Pain Syndrome with a site in China — 1 open to participants now, 3 under way, none of them phase 3. Patellofemoral Pain Syndrome · China.
Among the 11 studies in Patellofemoral Pain Syndrome with a site in China, this one is one of 5 that started in 2026, is one of 9 with no phase, and was the 10th registered.
297 studies on the registry are indexed under Patellofemoral Pain Syndrome; 73 are open to participants now.
Browse Patellofemoral Pain Syndrome studies →1 of the 11 studies in Patellofemoral Pain Syndrome with a site in China is open now. Recruiting first, the newest first:
Peking University Third Hospital · Sites in China
Ages 18–50
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 44 Patellofemoral Pain Syndrome studies recruiting now, 3 (7%) set no upper age limit and 40 (91%) stop at 75 or younger; 6 take children under 18; 12 take healthy volunteers.
This study: 18 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
11 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 5 started in 2026.
This study's enrollment of 60 is above the median of 45 across 244 interventional studies indexed under Patellofemoral Pain Syndrome.
Median enrollment 84 across the 9 interventional studies, 46 across the 2 observational. Of the 8 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 11 has an industry lead sponsor. The 5 most frequent:
Nanjing Mingzhou Rehabilitation Hospital is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Nanjing Mingzhou Rehabilitation Hospital has 1 study filed under Patellofemoral Pain Syndrome — fewer than ten, so there is no comparison to draw.
2 of the studies in Patellofemoral Pain Syndrome with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07557797Beijing Sport UniversityGait Retraining for Runners With Patellofemoral Pain | 2026-12-15 |
| NCT07557784Beijing Sport UniversityTelerehabilitation for Patellofemoral Pain | 2026-12-20 |
Add all 2 to your calendar (.ics) → With an account.
Among the 11 studies in Patellofemoral Pain Syndrome with a site in China, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial aims to investigate the effects of isokinetic training combined with blood flow restriction (BFR) in individuals with patellofemoral pain syndrome (PFPS).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Isokinetic Training Combined With Blood Flow Restriction
Device: Isokinetic Training Combined With Blood Flow Restriction
Isokinetic Training
Device: Isokinetic Training
Aerobic Cycling Exercise
Device: Aerobic Cycling Exercise
Participants in this group will receive supervised isokinetic muscle strength training targeting the knee musculature using an isokinetic dynamometer. Each session will last 30 minutes throughout the intervention period.
Participants in this group will receive isokinetic muscle strength training combined with blood flow restriction (BFR). BFR will be applied to the proximal thigh using a pneumatic cuff at an individualized pressure based on limb occlusion pressure. Isokinetic training will target the knee musculature using an isokinetic dynamometer under supervised conditions. Each session will last 30 minutes, with training performed multiple times per week throughout the intervention period.
Participants in this group will receive supervised aerobic cycling exercise using a stationary bicycle. Training will be performed at a moderate intensity for 30 minutes per session throughout the intervention period.
Anterior Knee Pain Scale (AKPS)
The AKPS is a validated questionnaire used to assess pain and functional limitations associated with patellofemoral pain syndrome. Scores range from 0 to 100, with higher scores indicating better knee function and fewer symptoms.
Time frame: From enrollment to the end of treatment at 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2026 to primary completion in Aug 2026, 2 months.
Of 153 non-industry interventional studies with no phase under Patellofemoral Pain Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 21. This study's 2 months is below that.
Counting every sponsor, half of 157 studies reached it within 11 months; a quarter within 4 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patellofemoral Pain Syndrome →
Nanjing Mingzhou Rehabilitation Hospital